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ABSTRACT
Objective: To evaluate clinical, epidemiological and laboratorial aspects for the understanding of the 
disease characteristics and its relationship with diagnostic tests. Methods: A retrospective, descriptive 
and analytical study involving 2,660 American cutaneous leishmaniasis (ACL) suspected patients from 
southern Brazil was undertaken between April 1986 and December 2005. Data on population char-
acteristics and laboratory tests were obtained. Diagnostic laboratory tests used were direct search for 
Leishmania spp. (DS), Montenegro skin test (MST) and indirect immunoﬂ uorescent assay (IFA). Re-
sults: 62.3% of patients were positive for at least one laboratory test. DS test was positive in 65.1%; MST 
in 92.3% and IFA in 70.0%. Although Cohen’s Kappa test did not reveal any agreement with laboratory 
diagnosis for ACL, the association between MST and IFA tests increased positiveness to 98.9%; MST 
and DS to 97.2%; and IFA and DS to 85%. IFA and MST positiveness were higher among patients with 
≤ 2-month lesion-evolution time. Most ACL patients were male (72.6%) in the age range of 15-49 years, 
featuring lesions during two months or less (53.9%) and a cutaneous form of the disease (88.0%). Con-
clusion: Findings suggest that for the adequate identifi cation of ACL cases a combination of laboratory 
tests that involves the association of MST with at least another test should be used.
Keywords: clinical laboratory techniques; disease transmission; infectious; cutaneous leishmaniasis; 
epidemiology.
[Braz J Infect Dis 2011;15(1):12-16]©Elsevier Editora Ltda.
INTRODUCTION
American cutaneous leishmaniasis (ACL) is 
transmitted by bites from insects of the Phle-
botomine family, which inoculate the host’s der-
mis with protozoa of the Leishmania genus and 
cause an ulcer on the site. When the species is 
Leishmania (Viannia) braziliensis, a mucocu-
taneous destructive lesion ensues in the naso-
oropharynx area. It has been observed that cu-
taneous ulcers, whether treated or not, tend to 
heal after several months. However, smooth and 
shiny scars, characterized as atrophic, hairless, 
and depressed with hypo- or hyper-pigmented 
areas, become residual.1 Although cases of re-
lapse and/or progression to the mucocutaneous 
type may occur after treatment despite complete 
healing of the initial lesion,2-5 inadequate or in-
complete treatment of the initial ulcer seems to 
be an important factor in its development. 6-8
ACL occurs throughout the Americas, from 
southern United States to northern Argen-
tina. The disease is found in almost all Latin 
American countries, with the exception of Chile 
and Uruguay.9 ACL is found in all Brazilian 
states and infects both sexes and all age brack-
ets.10 L. (V.) braziliensis is predominantly the 
ACL agent in the southern state of Paraná, with 
disease reported in 289 of the 399 municipalities. 
ACL has been reported in Paraná since the start 
of the 20th century when the region was settled 
by white people and the original forest was de-
stroyed to make way for coffee, soya bean, wheat 
and other crops. However, remnants of original 
forest remain, especially in the neighborhood of 
many rivers and streams. In fact, they provide a 
favorable environment for wild animal species 
and other abundant vectors, reservoirs of Leish-
mania, throughout the state.10-11
Direct microscopy for parasite search in 
the lesions and the Montenegro skin test for 
hypersensitivity to Leishmania antigens are 
the most frequent tests for ACL laborato-
rial diagnosis. Serological tests, such as in-
direct immunofluorescent assay (IFA), en-
zyme immunoassay (EIA) and polymerase
chain reaction (PCR), have produced satisfac-
tory results.12-14 Direct search for parasites in 
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lesions and the Montenegro skin test have been recom-
mended at the Brazilian Public Health Centers, which, to-
gether with the clinical aspects of lesion and epidemiological 
antecedents, provide the basis for ACL diagnosis.15
In the current study, suspected ACL patients seen at a re-
gional reference laboratory for diagnosing the disease were 
investigated to evaluate their clinical, epidemiological and 
laboratory aspects, and the relationship between disease’s 
characteristics and diagnostic tests.
MATERIAL AND METHODS
Area of study 
The state of Paraná lies in southern Brazil, with the Tropic of 
Capricorn passing throughout its northern region. In the cur-
rent study, the municipalities lie in the state northwestern, 
northern-central north and western-central meso-regions. 
This vast region has been depleted of most of its native tropi-
cal and subtropical forests, with remnants of forest residues 
along the banks of large rivers and their tributaries, such as the 
Ivaí, Paraná and Paranapanema rivers. The region’s population 
amounts to approximately 683,563 inhabitants and its econo-
my is mainly based on agriculture and live-stock raising, with 
important secondary food, textile, confectionary and furniture 
industries producing sectors. Since the fi rst decades of the 20th 
century the region has been settled by Italian, German, and Jap-
anese immigrants and by migrants from other Brazilian states, 
such as São Paulo and Rio Grande do Sul, in search for land to 
plant coffee and, later, live-stock raising.
Population
Between April 1986 and December 2005, 2,660 suspected 
ACL patients were seen at the Laboratory of Teaching and 
Research in Clinical Analyses of the Universidade Estadual 
de Maringá (LEPAC/UEM), Maringá PR Brazil. The study 
included 1,656 patients with clinical diagnosis of ACL which 
had at least one positive laboratory test.
Study design
Analysis was retrospective, descriptive and information was 
obtained by means of a standardized epidemiological ques-
tionnaire fi lled in with the patients’ details collected at the 
time of performing laboratory diagnostic tests.
Variables of interest
Gender, age, location of residence, duration and evolution of the 
lesion, type and location of lesions, and laboratory test results.
Diagnostic techniques 
(I) Direct search for Leishmania spp. (DS): samples, col-
lected from suspected patients, were obtained by the scrap-
ing of lesions. Glass slides were made from the material and 
stained with Giemsa. They were then examined under the mi-
croscope for Leishmania spp.; (II) Montenegro skin test (MST): 
0.1 mL of antigen (supplied by the Immunobiological Produc-
tion and Research Centre – CPPI PR Brazil) was inoculated on 
the front side of the patient’s forearm. The antigen suspension 
was composed of promastigote forms of L. (Leishmania) ama-
zonensis in 40 µg/mL of protein nitrogen. Reading, undertaken 
48-72h after inoculation, was positive when a ≥ 5 mm di-
ameter cutaneous induration was present;16 and (III) Indirect 
immunoﬂ uorescent assay (IFA): serum samples were stored at 
4°C until the tests were carried out, and at -20°C thereafter. IFA 
technique for IgG antibodies was performed with promastigote 
forms of L. (V.) braziliensis. Serum was diluted from 1/20 in 
ratio 2, employing human anti-IgG-ﬂ uorescein isothiocyanate 
conjugate. Samples with titers ≥ 40 were considered positive.16
Statistical analysis 
Data were pooled and analyzed with Excel and Statistica 5.0. 
Chi-square and Mantel-Haenszel association tests were used 
to compare categorical variables. The signifi cance level was 
0.05. Agreement beyond chance among tests was assessed by 
Cohen’s Kappa Statistics (< 0 no agreement; 0-0.19 poor; 
0.20-0.39 fair; 0.40-0.59 moderate; 0.60-0.79 substantial and 
0.80-1.00 almost perfect).17
Ethical principles 
The current investigation was evaluated and approved by 
the Permanent Committee for Ethics in Research Involving 
Human Beings (COPEP) of the Universidade Estadual de 
Maringá. (Protocol 080/2006).
RESULTS
In the current study, out of 2,660 patients referred for labo-
ratory tests 1,656 (62.3%) with at least one positive labora-
tory test were selected. Specifi cally, DS technique was posi-
tive in 65.1% of the study sample; MST technique in 92.3%; 
and IFA technique in 70.0%.
When MST and DS tests were associated (Table 1), 59.4% 
of the patients were positive for both tests. However, no agree-
ment beyond chance between the two tests could be demon-
strated (Kappa = -0.00063; 95% CI: -0.04438 – -0.03175). When 
IFA + DS tests were analyzed, 54.6% of patients were positive 
to both tests, featuring a fair agreement (Kappa = 0.2812; 95%
CI: 0.2292 – 0.3331). Furthermore, MST + IFA tests showed 
that 62.3% of patients were positive to both tests, with no 
agreement (Kappa = -0.07762; 95% CI: -0.01138 – -0.00415). 
On the other hand, MST + IFA tests increased positiveness to 
98.9%, MST + DS to 97.2%, and IFA + DS to 85%. 
Out of 1,656 patients with an ACL positive laboratory test 
(Figure 1), 39.4% had positive results for the three tests. On the 
other hand, 31.4% had positive results in two tests, whereas 29.2% 
had only one positive test. In fact, 74.9% MST-positive patients 
had also another positive test, and 92.1% of IFA-positive patients 
and 96.9% of DS-positive patients were positive for another test.
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The age bracket most affected by ACL was between 15 
and 49 years (66.1%). Variables associated with the above 
age bracket were: male (p = 0.00000); lesion-evolution time 
≤ 2 months (p = 0.00000); residence in an urban area 
(p = 0.00175); cutaneous form of the disease (p = 0.00000) 
(Table 3). In fact, most ACL patients were male (72.6%), 
had lesions with less than two month duration (53.9%) and 
featured the cutaneous form of the disease (88.0%).
Table 3. Patients with positive American cutaneous 
leishmaniasis laboratory diagnosis according to 
gender, lesion evolution time, location of residence 
and form of the disease, Maringá- Paraná, Brazil, 
1986-2005
Variable            Age   
p*
 0 - 14 15 - 9 > 50 Total 
Sex 
 Male 61 842 297 1,200
 Female 59 252 143 454 0.00000
 Total 120 1,094 440 1,654
Lesion-evolution 
time
 ≤ 2 months 83 629 180 892
 ≥ 2 months 37 465 260 762 0.00000
 Total 120 1,094 440 1,654
Residence
 Urban 75 769 318 1,132
 Rural 73 317 118 508 0.00175
 Total 118 1,086 436 1,640
Form
 Cutaneous 118 1,003 329 1,450
 Mucosal 1 87 110 198 0.00000
 Total 119 1,090 439 1,648 
*χ2 Mantel-Haenszel test.
Table 1. Results of the direct parasite search, Monte-
negro skin test and indirect immunofluorescent assay 
tests performed on American cutaneous leishmaniasis 
patients, Maringá - Paraná, Brazil, 1986-2005
MST
  DS  Total Kappa statistic
 Positive  Negative  (CI 95%)
Positive 771  419 1,190 0.000631
Negative 71  36 107 0.04438
Total 842  455 1,297 0.03175
IFA
  DS  
Total
 
 Positive  Negative  
Positive 737  272 1,009 0.2812
Negative 141  200 341 0.2292
Total 878  472 1,350 0.3331
IFA
  MST  
Total
 
 Positive  Negative  
Positive 971  104 1,075 0.07762
Negative 467  17 484 0.1138
Total 1438  121 1,559 0.00415
DS, direct search; MST, Montenegro skin test; IFA, indirect 
immunofluorescent; CI, confidence interval.
Table 2. Indirect immunofluorescent assay and 
Montenegro skin test results according to American 
cutaneous leishmaniasis evolution time in patients 
with positive diagnosis, Maringá- Paraná, Brazil, 
1986-2005
         Lesion-evolution time (months)
  ≤ 2 > 2 Total p value
IFA (titles)
 40-80 463 321 784 
0.0000
 ≥ 160 208 111 319
Total  671 432 1,103 
MST (mm)
 5 a 10 362 227 589 
0.7916
 > 10 425 360 785
Total  787 587 1,374 
IFA, indirect immunofluorescent; MST, Montenegro skin test; 
χ2 test.
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Figure 1: Combined results of the laboratory tests performed 
on the 1,656 patients with positive diagnosis of American 
cutaneous leishmaniasis in the period from 1986 to 2005 in 
Maringá – Paraná, Brazil. 
When IFA and MST tests results were analyzed with re-
gard to lesion-evolution time (Table 2), IFA positiveness was 
higher among patients with a lesion-evolution time of ≤ 2 
months, with 71.1% of patients manifesting titers of 40-80 (p = 
0.0000). Most patients (57.3%) with a positive MST result had 
a ≤ 2 months lesion-evolution time and a > 10 mm induration 
diameter (54.1%). However, there was no association between 
induration diameter and lesion-evolution time (p = 0.7916).
MST, Montenegro skin test; DS, direct search; IFA, indirect 
immunofluorescent assay.
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DISCUSSION
ACL is a public health problem in Brazil and in the state of 
Paraná, Brazil, where the fi rst case of the disease was report-
ed in 1917. It has been on the increase since 1980.10
In current study, MST was positive in 92.3%, IFA in 
70.0% and DS in 65.1% of ACL-suspected patients. Results 
of another study conducted in the same geographical area 
had very similar positiveness rates (91.1% for MST, 64.4% 
for IFA and 59.4% for DS).18 Barreto et al. obtained a 54.4% 
positiveness rate for IFA in patients with active lesions,2 
while Pappas et al. obtained 82.0%.19 Moreover, Szargiki et 
al., using parasitological methods, detected 79.3% of the pa-
tients with clinical diagnosis, and demonstrated a 95% sen-
sitivity with serological methods for homologous antigens.20 
However, when IFA and MST positiveness rates were ana-
lyzed for diseased patients, rates reached 83.9% and 91.6%, 
respectively.
Since the current analysis showed that no consistency 
among the three laboratory tests studied for ACL diagnosis, 
one could suggest that the simultaneous use of two or more 
tests is the most reliable way of successfully identifying ACL 
cases. Silveira et al. also found that the association of tech-
niques conferred greater reliability to the ACL laboratory di-
agnosis and suggested that MST should always be associated 
with DS or IFA techniques.18 In fact, it is interesting to note 
that 39.4% of patients in the present study had positive re-
sults for the three laboratory tests and 31.4% had posi-
tive results for at least two of the three tests.
It was also observed that most patients with positive IFA 
or MST results had a lesion evolution time of less than two 
months. Results reinforce the importance of these tests for 
patients with recent lesions and are in accordance with data 
reported by Silveira et al. who found that up to 96.3% of 
patients with positive MST and IFA results showed disease 
evolution of up to one month.18
Higher frequency of ACL cases among males between 
the ages of 15 and 49 has also been reported in other 
states.21-23 The current study showed that most patients 
had the cutaneous form of the disease, lived in urban 
environments and acquired ACL during work or leisure 
activities. It has been observed that in Latin America and 
in Brazil a significant decrease in forest areas has led to 
an ACL increase in urban regions which, consequently, 
requires new methods of disease control.24-25 On the other 
hand, the understanding of ACL transmission dynamics 
and the relationship between the environmental and so-
cio-economic factors that contribute to its maintenance 
are mandatory.26
The predominance of cases among males, the low number 
of cases among those under 14 years, and most people acquir-
ing the disease during work activities coincides with the char-
acteristics of the social and economic model of the southern 
region of Brazil and of the state of Paraná. Migration to urban 
centers has been on the rise in the state of Paraná where the 
lack of formal labor has forced individuals to seek occasional 
work on sugarcane, soya bean and wheat plantations, and 
in small agro-industrial companies. Through this process, 
males, hailing from the towns, return to the countryside and 
reduce and degrade forest environments, forcing wild animals 
into the urban areas and thereby creating urban foci of the 
disease.27 The above description of ACL in the state of Paraná 
coincides with that reported by Monteiro et al. in which most 
ACL cases occur within the green belts of the town and cities 
in which fragments of modifi ed native forest still exists.28 This 
factor coupled to a density of phlebotomies and to the free 
circulation of the wild animal reservoirs, is the basis for ACL 
persistence in the state.
CONCLUSION
This study showed that the majority of patients had the 
cutaneous form of ACL, lived in urban environments and 
acquired it during work or leisure activities, with predomi-
nance of cases in the male population, and low number of 
cases among under 14-year-old individuals. The persistence 
of ACL, with the characteristics of an urban disease but with 
innumerable cases associated with the rural environment, 
is a challenge. In this context, the identifi cation of the dis-
ease is important not only for its early and correct treatment 
but as a general guide for health public policy in its control. 
Results of the current investigation suggest a combination 
of laboratorial tests involving the association of at least two 
types of tests, of which one should be the MST, for adequate 
identifi cation of ACL.
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